Jesús María Hernández-Rivas (Jesús María Hernández Rivas, Jesús M Hernandez-Rivas, Jesús-María Hernández-Rivas, Jesús Maria Hernández-Rivas, Jesús M Hernández-Rivas)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Multiple Myeloma

Intellectual Disability

Chronic Lymphocytic Leukemia

Top Venues

American journal of hematology

European journal of clinical investigation

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Elias J Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, Pilar Martínez-Sánchez, José J Rifón Roca, Ryan D Cassaday, Boris Böll, Anita Rijneveld, Maher Abdul-Hay, Françoise Huguet, Thomas Cluzeau, Mar Tormo Díaz, Vladan Vucinic, José González-Campos, Alessandro Rambaldi, Stefan Schwartz, Céline Berthon, Jesús María Hernández-Rivas, Paul R Gordon, Monika Brüggemann, Ali Hamidi, Yuqi Chen, Hansen L Wong, Bharat Panwar, Yuliya Katlinskaya, Ana Markovic, Hagop M Kantarjian
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia. American journal of hematology 99 (4) (2024)
Elias J Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, Pilar Martínez-Sánchez, José J Rifón Roca, Ryan D Cassaday, Boris Böll, Anita Rijneveld, Maher Abdul-Hay, Françoise Huguet, Thomas Cluzeau, Mar Tormo Díaz, Vladan Vucinic, José González-Campos, Alessandro Rambaldi, Stefan Schwartz, Céline Berthon, Jesús María Hernández-Rivas, Paul R Gordon, Monika Brüggemann, Ali Hamidi, Yuqi Chen, Hansen L Wong, Bharat Panwar, Yuliya Katlinskaya, Ana Markovic, Hagop M Kantarjian
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia. American journal of hematology 99 (4) (2024)
Alberto Hernandez-Sanchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa María Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, J Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy Cirici, Manuel Mateo Pérez Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Carlos Hernández-Boluda, null null
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology 99 (4) (2024)
Rita Salvado, Sandra Santos-Minguez, Cristina Lugones-Sánchez, Susana González-Sánchez, Olaya Tamayo-Morales, José Antonio Quesada Rico, Rocío Benito, Emiliano Rodriguez-Sanchez, Manuel Angel Gomez-Marcos, Verónica Casado-Vicente, Pedro Cunha, Jesús María Hernández-Rivas, Alejandro Mira, Luis García-Ortiz, null null
Gut microbiota and its relationship with early vascular ageing in a Spanish population (MIVAS study). European journal of clinical investigation (2024)
Claudia Pérez-Carretero, Teresa González, Miguel Quijada Álamo, Gian Matteo Rigolin, Adrian Dubuc, Ángela Villaverde Ramiro, Alberto Rodríguez-Sánchez, Araceli Rubio, Julio Dávila-Valls, Mª Jesús Vidal, Isabel González-Gascón Y Marín, José-Ángel Hernández-Rivas, Rocío Benito, Virginia Volpe, Matthew S Davids, Jeremy S Abramson, Antonio Cuneo, Paola Dal Cin, Ana Eugenia Rodríguez Vicente, Jesús María Hernández-Rivas
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis. American journal of hematology 99 (9) (2024)
Alberto Hernandez-Sanchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa María Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, J Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy Cirici, Manuel Mateo Pérez Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Carlos Hernández-Boluda, null null
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology (2024)
Alberto Hernandez-Sanchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa María Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, J Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy Cirici, Manuel Mateo Pérez Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Carlos Hernández-Boluda, null null
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology 99 (4) (2024)
Rita Salvado, Sandra Santos-Minguez, Cristina Lugones-Sánchez, Susana González-Sánchez, Olaya Tamayo-Morales, José Antonio Quesada Rico, Rocío Benito, Emiliano Rodriguez-Sanchez, Manuel Angel Gomez-Marcos, Verónica Casado-Vicente, Pedro Cunha, Jesús María Hernández-Rivas, Alejandro Mira, Luis García-Ortiz, null null
Gut microbiota and its relationship with early vascular ageing in a Spanish population (MIVAS study). European journal of clinical investigation 54 (9) (2024)
Claudia Pérez-Carretero, Teresa González, Miguel Quijada Álamo, Gian Matteo Rigolin, Adrian Dubuc, Ángela Villaverde Ramiro, Alberto Rodríguez-Sánchez, Araceli Rubio, Julio Dávila-Valls, Mª Jesús Vidal, Isabel González-Gascón Y Marín, José-Ángel Hernández-Rivas, Rocío Benito, Virginia Volpe, Matthew S Davids, Jeremy S Abramson, Antonio Cuneo, Paola Dal Cin, Ana Eugenia Rodríguez Vicente, Jesús María Hernández-Rivas
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis. American journal of hematology (2024)
Elias J Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, Pilar Martínez-Sánchez, José J Rifón Roca, Ryan D Cassaday, Boris Böll, Anita Rijneveld, Maher Abdul-Hay, Françoise Huguet, Thomas Cluzeau, Mar Tormo Díaz, Vladan Vucinic, José González-Campos, Alessandro Rambaldi, Stefan Schwartz, Céline Berthon, Jesús María Hernández-Rivas, Paul R Gordon, Monika Brüggemann, Ali Hamidi, Yuqi Chen, Hansen L Wong, Bharat Panwar, Yuliya Katlinskaya, Ana Markovic, Hagop M Kantarjian
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia. American journal of hematology 99 (4) (2024)
Elias J Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, Pilar Martínez-Sánchez, José J Rifón Roca, Ryan D Cassaday, Boris Böll, Anita Rijneveld, Maher Abdul-Hay, Françoise Huguet, Thomas Cluzeau, Mar Tormo Díaz, Vladan Vucinic, José González-Campos, Alessandro Rambaldi, Stefan Schwartz, Céline Berthon, Jesús María Hernández-Rivas, Paul R Gordon, Monika Brüggemann, Ali Hamidi, Yuqi Chen, Hansen L Wong, Bharat Panwar, Yuliya Katlinskaya, Ana Markovic, Hagop M Kantarjian
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia. American journal of hematology (2024)
Alberto Hernandez-Sanchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa María Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, J Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy Cirici, Manuel Mateo Pérez Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Carlos Hernández-Boluda, null null
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology 99 (4) (2024)
Anna Torrent Catarineu, Mireia Morgades, Olga García-Calduch, María Paz Queipo de Llano, Pau Montesinos, Irene Navarro, Jesús María Hernández-Rivas, Abelardo Bárez-García, José González-Campos, Itziar Oiartzabal, Marta Valero, Marta Cervera, Teresa Zudaire Ripa, Manuel Albors-Ferreiro, Oriana Lopez-Godino, Cristina Gil-Cortés, Lucía Villalón, Raquel Saldaña, Josep-María Ribera
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain. European journal of haematology (2023)
Sofía Toribio-Castelló, Sandra Castaño-Díez, Ángela Villaverde-Ramiro, Esperanza Such, Montserrat Arnán, Francisco Solé, Marina Díaz-Beyá, Maria Diez Campelo, Mónica Del Rey, Teresa González, Jesús María Hernández-Rivas
Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8. Cancers 15 (15) (2023)
Elena Vuelta, José L Ordoñez, David J Sanz, Sandra Ballesteros, Jesús María Hernández-Rivas, Lucía Méndez-Sánchez, Manuel A Sanchez-Martin, Ignacio García-Tuñon
CRISPR/Cas9-Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML. International journal of molecular sciences 23 (12) (2022)
Claudia Pérez-Carretero, María Hernández-Sánchez, Teresa González, Miguel Quijada-Álamo, Marta Martín-Izquierdo, Sandra Santos-Mínguez, Cristina Miguel-García, María-Jesús Vidal, Alfonso García-De-Coca, Josefina Galende, Emilia Pardal, Carlos Aguilar, Manuel Vargas-Pabón, Julio Dávila-Valls, Isabel Gascón-Y-Marín, José-Ángel Hernández-Rivas, Rocío Benito, Jesús María Hernández-Rivas, Ana Eugenia Rodríguez Vicente
TRAF3 alterations are frequent in del-3'IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features. American journal of hematology 97 (7) (2022)
Ana Marín-Quilez, Christian Andrea Di Buduo, Lorena Díaz-Ajenjo, Vittorio Abbonante, Elena Vuelta, Paolo Maria M Soprano, Cristina Miguel-García, Sandra Santos-Minguez, Inmaculada Serramito-Gómez, Pedro Ruiz-Sala, M Jesús Peñarrubia, Emilia Pardal, Jesús María Hernández-Rivas, José Ramón González-Porras, Ignacio García-Tuñón, Rocío Benito, José Rivera, Alessandra Balduini, José Maria Bastida
Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis. Blood (2022)
Mattia D'Agostino, David A Cairns, Juan-José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos-Manteca, Daniele Dall'Olio, Niels W C J van de Donk, Graham H Jackson, Serena Rocchi, Hans J Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone C Castellani, Francesca Bonello, Andrea Capra, Elias Karl Mai, Jan Dürig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F Kaiser, Hartmut Goldschmidt, Jesús María Hernández-Rivas, Alessandra Larocca, Curly T C M Morris, Jesús San F Miguel, Mario Boccadoro, Pieter Sonneveld
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Miguel Quijada-Álamo, María Hernández-Sánchez, Ana Eugenia Rodríguez Vicente, Claudia Pérez-Carretero, Alberto Rodríguez-Sánchez, Marta Martín-Izquierdo, Verónica Alonso-Pérez, Ignacio García-Tuñon, José Maria Bastida, María Jesús Vidal-Manceñido, Josefina Galende, Carlos Aguilar, José Antonio Queizán, Isabel González-Gascón Y Marín, José-Ángel Hernández-Rivas, Rocío Benito, José Luis Ordóñez, Jesús María Hernández-Rivas
Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression. Blood cancer journal 11 (7) (2021)
Claudia Pérez-Carretero, Isabel González-Gascón Y Marín, Ana Eugenia Rodríguez Vicente, Miguel Quijada-Álamo, Jose-Ángel Hernández-Rivas, María Hernández-Sánchez, Jesús María Hernández-Rivas
The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment. Diagnostics (Basel, Switzerland) 11 (5) (2021)
Miguel Quijada-Álamo, Claudia Pérez-Carretero, María Hernández-Sánchez, Ana-Eugenia Rodríguez-Vicente, Ana-Belén Herrero, Jesús-María Hernández-Sánchez, Marta Martín-Izquierdo, Sandra Santos-Mínguez, Mónica Del Rey, Teresa González, Araceli Rubio-Martínez, Alfonso García de Coca, Julio Dávila-Valls, José-Ángel Hernández-Rivas, Helen Parker, Jonathan C Strefford, Rocío Benito, José-Luis Ordóñez, Jesús María Hernández-Rivas
Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia. Clinical and translational medicine 11 (2) (2021)